Company intelligence / Profile preview

Valcon Medical

Lynge (Greater Copenhagen), Capital Region (Hovedstaden), Denmark

Ownership: Private
Development stage: Other

Overview

Valcon Medical’s standardized medical cannabis oil products are approved by the Danish Medicines Agency; products are distributed in several European countries and include Denmark’s first medical cannabis inhalation product for pain relief

Therapeutic areas: OtherNeurology
Modalities: Small molecule (cannabinoids extracted from Cannabis sativa L. flowers)Herbal extractOil formulation
Industry: Biotech

Partnerships

Partnership with Polish manufacturer of medicinal cannabisDistribution partnerships in Germany, Denmark, UK, Poland, and broader Europe

Beyond the preview

Go deeper on Valcon Medical.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Valcon Medical.

Explore the full profile